Florida

Back to map

Showing 1-10 of 27 grants

Title Institution Researcher Program Duration Total Award Amount
Repurposing Cardiorenal Drugs for T1D: Building Evidence from Existing Trials (ReCaRD T1D) AdventHealth Richard Pratley Improving Lives 01-September-2023 to 20-November-2026 $110.840,00
Clinical Translation of NICHE for pancreatic islet transplantation for T1D Continuity Biosciences Alessandro Grattoni Cures 01-March-2026 to 28-February-2030 $2.675.316,00
Advanced Preclinical Development of iTOL-101, a Combination Investigational Product Composed of A Biotechnology-Derived Chimeric Streptavidin and A Fas Ligand (SA-FasL) Protein Bound to Biotinylated Hydrogel-Based Microparticles (Microgel) and Mixed with Deceased Donor Human Pancreatic Islets for the Treatment of Poorly-Controlled (or “Brittle”) Type 1 Diabetes iTolerance, Inc. Camillo Ricordi Cures 01-June-2022 to 31-March-2027 $850.000,00
Studies of Promising Functional Endpoints in Eyes of Patients with Diabetes (Protocols AR and AS ) Jaeb Center for Health Research Adam Glassman Improving Lives 01-May-2026 to 30-April-2030 $1.035.583,00
Randomized Clinical Trial Evaluating Fenofibrate for Prevention of Diabetic Retinopathy Worsening Jaeb Center for Health Research Adam Glassman Improving Lives 01-February-2021 to 31-August-2026 $750.000,00
JDRF T1D Coordinating Center Jaeb Center for Health Research Judy Sibayan Transportfolio 01-August-2019 to 31-August-2027 $2.914.531,01
Transdisciplinary Care for Young Adults with Type 1 Diabetes Transitioning to Adult Healthcare Nemours Children’s Clinic Jessica Pierce Improving Lives 01-May-2023 to 30-April-2028 $640.819,87
Understanding Early Histopathological Changes in the Pancreas of those at Risk for Type 1 Diabetes Development University of Florida Alexandra Rippa Cures 01-March-2026 to 28-February-2029 $237.690,00
Cord Blood Proteomic Markers of Type 1 Diabetes Risk: Towards Validation in a Diverse Birth Cohort University of Florida Angelica Ahrens Cures 01-April-2026 to 31-March-2027 $199.235,28
NIICHE: A Human 3‑D Pancreatic Hydrogel Platform for Real‑Time Investigation of β‑Cell Immunogenicity and Therapeutic Screening in Type 1 Diabetes University of Florida Cherie Stabler Cures 01-October-2026 to 30-September-2027 $300.000,00